For decades, the field of genomics has grappled with increasingly complex questions of ethics. When the great philosophizers speculated on the human condition thousands of years ago, they almost certainly did so without ever imagining we’d one day have the ability to manipulate our own genetic code.
What are the biggest bioethical challenges in genomics today, and more importantly, for the decades to come? The path we lay over the next few years could set the stage for mankind’s acceptance of – or skepticism in – the science.
Precision medicine is quickly moving from the research phase to clinical application. The science of using genes, proteins, and environmental information to provide personalized patient treatment isn’t a new one, but technology is finally catching up to speculation.
IMCS is a biotechnology company helping to advance the science of precision medicine. Our groundbreaking IMCStips are designed to produce consistent, repeatable results within the proteomics field, and we’re proud to say they’re being used in research laboratories all over the country.
Here are three impending changes on the horizon for the science of precision medicine.